Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth A. Purdom, Victoria Wang, Yuan Qi, Matthew D. Wilkerson, C. Ryan Miller, Li Ding, Todd R. Golub, Jill P. Mesirov, Gabriele Alexe, Michael S. Lawrence, Michael O'Kelly, Pablo Tamayo, Barbara A. Weir, Stacey Gabriel, Wendy Winckler, Supriya Gupta, Lakshmi R. Jakkula, Heidi S. Feiler, John Hodgson, Charles David James, Jann Nagina Sarkaria, Cameron Brennan, A Kahn, Paul T. Spellman, Richard K. Wilson, Terence Paul Speed, Joe W. Gray, Matthew M. Meyerson, Gad A. Getz, Charles M. Perou, David Neil Hayes
Cancer Cell · 2010 · 7,754 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Verhaak, R. G., Hoadley, K. A., Purdom, E. A., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T. R., Mesirov, J. P., Alexe, G., Lawrence, M. S., O’Kelly, M., Tamayo, P., Weir, B. A., Gabriel, S., Winckler, W., Gupta, S., Jakkula, L. R., … Hayes, D. N. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17(1), 98–110. https://doi.org/10.1016/j.ccr.2009.12.020
In text: (Verhaak et al., 2010)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma multiforme (GBM). We describe a robust gene expression-based molecular classification of GBM into Proneural, Neural, Classical, and Mesenchymal subtypes and integrate multidimensional genomic data to establish patterns of somatic mutations and DNA copy number. Aberrations and gene expression of EGFR, NF1, and PDGFRA/IDH1 each define the Classical, Mesenchymal, and Proneural subtypes, respectively. Gene signatures of normal brain cell types show a strong relationship between subtypes and different neural lineages. Additionally, response to aggressive therapy differs by subtype, with the greatest benefit in the Classical subtype and no benefit in the Proneural subtype. We provide a framework that unifies transcriptomic and genomic dimensions for GBM molecular stratification with important implications for future studies.
Related papers
- The 2007 WHO Classification of Tumours of the Central Nervous System2007
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary2021
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-20102013
- MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma2005
- The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)2014
Metadata from OpenAlex (CC0). Citations are generated from the published record.